I am a
Home I AM A Search Login

Papers of the Week

Papers: 10 Aug 2019 - 16 Aug 2019

Human Studies, Pharmacology/Drug Development

2019 Aug 09

MMWR Morb Mortal Wkly Rep



Vital Signs: Pharmacy-Based Naloxone Dispensing – United States, 2012-2018.


Guy GP, Haegerich TM, Evans ME, Losby JL, Young R, Jones CM
MMWR Morb Mortal Wkly Rep. 2019 Aug 09; 68(31):679-686.
PMID: 31393863.


The CDC Guideline for Prescribing Opioids for Chronic Pain recommends considering prescribing naloxone when factors that increase risk for overdose are present (e.g., history of overdose or substance use disorder, opioid dosages ≥50 morphine milligram equivalents per day [high-dose], and concurrent use of benzodiazepines). In light of the high numbers of drug overdose deaths involving opioids, 36% of which in 2017 involved prescription opioids, improving access to naloxone is a public health priority. CDC examined trends and characteristics of naloxone dispensing from retail pharmacies at the national and county levels in the United States.